image
Healthcare - Biotechnology - NASDAQ - US
$ 6.545
-4.64 %
$ 654 M
Market Cap
-14.0
P/E
BALANCE SHEET
111 M ASSETS
24.05%
11.3 M LIABILITIES
64.18%
99.6 M EQUITY
20.71%
BALANCE SHEET DECOMPOSITION
Balance Sheet Trevi Therapeutics, Inc.
image
Current Assets 109 M
Cash & Short-Term Investments 108 M
Receivables 0
Other Current Assets 1.81 M
Non-Current Assets 1.47 M
Long-Term Investments 0
PP&E 1.23 M
Other Non-Current Assets 243 K
97.04 %Total Assets$110.9m
Current Liabilities 10.5 M
Accounts Payable 3.41 M
Short-Term Debt 285 K
Other Current Liabilities 6.81 M
Non-Current Liabilities 747 K
Long-Term Debt 0
Other Non-Current Liabilities 747 K
30.33 %60.50 %6.64 %Total Liabilities$11.3m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
ASSETS
Cash & Cash Equivalents 34.1 32.4 12.6 36.8 45.0 57.3 17.2 22.0 8.3
Short Term Investments 73.5 50.6 107.9 0 0 0 0 0 0
Receivables 0 0 0 0 0.3 0.6 0.2 0 0
Inventory 0 0 0 0 0.9 1.6 1.4 63 K 0
Other Current Assets 1.3 4.6 2.1 0.9 1.0 1.7 1.4 0.1 0.1
Total Current Assets 109.4 87.5 122.6 38.0 46.3 59.6 18.8 22.2 8.4
PP&E 1.2 1.6 0.2 0.2 0.3 0.4 0.1 14 K 5 K
Intangible Assets 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.2 0.3 0.2 0.3 0.5 19 K 1.6 52 K 12 K
Other Assets 0 0 0 0 0 0 0 0 0
Total Assets 110.9 89.4 123.0 38.5 47.1 60.0 20.5 22.2 8.4
LIABILITIES
Accounts Payable 3.4 1.8 2.9 2.8 2.0 1.6 0.6 0.5 0.4
Short Term Debt 0.3 0.3 7.0 6.0 0.2 0.2 0 5.3 17.0
Other Current Liabilities 6.8 3.7 3.5 3.9 3.3 3.4 2.1 1.3 3.0
Total Current Liabilities 10.5 5.8 13.4 12.7 5.6 5.2 2.7 7.1 20.4
Long Term Debt 0 1.0 2.2 8.7 14.1 0.3 1.1 0 5.1
Deferred Tax Income 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 3 K 0 0.2 0 0.5 0.3 0.3
Total Liabilities 11.3 6.9 15.6 21.4 19.8 5.5 3.2 7.5 25.8
EQUITY
Common Stock 94 K 68 K 60 K 29 K 19 K 18 K 0.1 4 K 4 K
Retained Earnings (287.0) (239.1) (210.1) (180.9) (147.0) (114.2) (109.5) (84.4) (72.2)
Other Accumulative Comprehensive Income/Loss 61 K 29 K (0.1) 0 0 (60.0) 46 K 23 K 0
Total Equity 99.6 82.5 107.5 17.1 27.3 54.5 17.3 14.8 (17.4)
Total Liabilities and Equity 110.9 89.4 123.0 38.5 47.1 60.0 20.5 22.2 8.4
SHARES OUTSTANDING
Common Shares Outstanding 101.0 99.0 64.5 22.8 18.1 11.7 9.0 9.0 16.1